Moderna Inc (MRNA)
107.97
+1.79
(+1.69%)
USD |
NASDAQ |
Apr 26, 16:00
107.80
-0.16
(-0.15%)
After-Hours: 20:00
Moderna Price to Book Value: 2.984 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 26, 2024 | 2.984 |
April 25, 2024 | 2.934 |
April 24, 2024 | 3.008 |
April 23, 2024 | 2.982 |
April 22, 2024 | 2.887 |
April 19, 2024 | 2.803 |
April 18, 2024 | 2.819 |
April 17, 2024 | 2.859 |
April 16, 2024 | 2.868 |
April 15, 2024 | 2.870 |
April 12, 2024 | 2.906 |
April 11, 2024 | 2.957 |
April 10, 2024 | 2.961 |
April 09, 2024 | 3.084 |
April 08, 2024 | 2.904 |
April 05, 2024 | 2.843 |
April 04, 2024 | 2.826 |
April 03, 2024 | 2.797 |
April 02, 2024 | 2.863 |
April 01, 2024 | 2.918 |
March 28, 2024 | 2.945 |
March 27, 2024 | 3.056 |
March 26, 2024 | 2.968 |
March 25, 2024 | 3.050 |
March 22, 2024 | 2.914 |
Date | Value |
---|---|
March 21, 2024 | 2.877 |
March 20, 2024 | 2.849 |
March 19, 2024 | 2.905 |
March 18, 2024 | 2.881 |
March 15, 2024 | 2.870 |
March 14, 2024 | 2.859 |
March 13, 2024 | 2.944 |
March 12, 2024 | 3.052 |
March 11, 2024 | 3.095 |
March 08, 2024 | 2.847 |
March 07, 2024 | 2.749 |
March 06, 2024 | 2.706 |
March 05, 2024 | 2.635 |
March 04, 2024 | 2.648 |
March 01, 2024 | 2.622 |
February 29, 2024 | 2.544 |
February 28, 2024 | 2.688 |
February 27, 2024 | 2.653 |
February 26, 2024 | 2.593 |
February 23, 2024 | 2.660 |
February 22, 2024 | 2.742 |
February 21, 2024 | 2.416 |
February 20, 2024 | 2.399 |
February 16, 2024 | 2.437 |
February 15, 2024 | 2.513 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.970
Minimum
Nov 09 2023
29.17
Maximum
Aug 09 2021
7.950
Average
4.310
Median
Feb 25 2022
Price to Book Value Benchmarks
Eli Lilly and Co | 64.74 |
Merck & Co Inc | 8.843 |
Pfizer Inc | 1.611 |
Johnson & Johnson | 5.121 |
Novavax Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 6.191 |
Price | 107.97 |
Earnings Yield | -11.49% |
Market Cap | 41.34B |